[go: up one dir, main page]

TW200607507A - Use of deoxypeganine for treating schizophrenic psychoses - Google Patents

Use of deoxypeganine for treating schizophrenic psychoses

Info

Publication number
TW200607507A
TW200607507A TW093135601A TW93135601A TW200607507A TW 200607507 A TW200607507 A TW 200607507A TW 093135601 A TW093135601 A TW 093135601A TW 93135601 A TW93135601 A TW 93135601A TW 200607507 A TW200607507 A TW 200607507A
Authority
TW
Taiwan
Prior art keywords
deoxypeganine
treating
schizophrenic psychoses
treating schizophrenic
derivative
Prior art date
Application number
TW093135601A
Other languages
English (en)
Inventor
Joachim Moormann
Klaus Opitz
Hilke Winterhoff
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34625212&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200607507(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of TW200607507A publication Critical patent/TW200607507A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
TW093135601A 2003-11-24 2004-11-19 Use of deoxypeganine for treating schizophrenic psychoses TW200607507A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10354893A DE10354893B4 (de) 2003-11-24 2003-11-24 Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen

Publications (1)

Publication Number Publication Date
TW200607507A true TW200607507A (en) 2006-03-01

Family

ID=34625212

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093135601A TW200607507A (en) 2003-11-24 2004-11-19 Use of deoxypeganine for treating schizophrenic psychoses

Country Status (23)

Country Link
US (1) US20070072947A1 (zh)
EP (1) EP1725229B1 (zh)
JP (1) JP2007512269A (zh)
KR (1) KR20070085036A (zh)
CN (1) CN1886127A (zh)
AR (1) AR046664A1 (zh)
AT (1) ATE424197T1 (zh)
AU (1) AU2004294689B2 (zh)
BR (1) BRPI0416411A (zh)
CA (1) CA2547171A1 (zh)
DE (2) DE10354893B4 (zh)
DK (1) DK1725229T3 (zh)
EA (1) EA012033B1 (zh)
ES (1) ES2323645T3 (zh)
IL (1) IL175772A0 (zh)
MY (1) MY141730A (zh)
NO (1) NO20062666L (zh)
NZ (1) NZ547103A (zh)
SI (1) SI1725229T1 (zh)
TW (1) TW200607507A (zh)
UA (1) UA86951C2 (zh)
WO (1) WO2005053673A1 (zh)
ZA (1) ZA200603543B (zh)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
DE19906975B4 (de) * 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19906979B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
DE19906977C1 (de) * 1999-02-19 2000-06-15 Lohmann Therapie Syst Lts Desoxypeganin-TTS und seine Verwendung
DE19906978B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
DE10119863A1 (de) * 2001-04-24 2002-11-07 Hf Arzneimittelforsch Gmbh Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen
DE10134038A1 (de) * 2001-07-12 2003-02-06 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
DE10163667B4 (de) * 2001-12-21 2006-10-26 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung der klinischen Depression

Also Published As

Publication number Publication date
AU2004294689B2 (en) 2010-01-07
DK1725229T3 (da) 2009-06-22
EA012033B1 (ru) 2009-06-30
MY141730A (en) 2010-06-15
JP2007512269A (ja) 2007-05-17
ES2323645T3 (es) 2009-07-22
BRPI0416411A (pt) 2007-01-09
US20070072947A1 (en) 2007-03-29
UA86951C2 (ru) 2009-06-10
EP1725229B1 (de) 2009-03-04
NZ547103A (en) 2009-07-31
CN1886127A (zh) 2006-12-27
ZA200603543B (en) 2007-03-28
ATE424197T1 (de) 2009-03-15
KR20070085036A (ko) 2007-08-27
DE10354893A1 (de) 2005-06-30
EA200601016A1 (ru) 2006-10-27
DE502004009105D1 (de) 2009-04-16
IL175772A0 (en) 2008-04-13
NO20062666L (no) 2006-06-09
WO2005053673A1 (de) 2005-06-16
HK1093696A1 (zh) 2007-03-09
DE10354893B4 (de) 2011-03-10
AU2004294689A1 (en) 2005-06-16
CA2547171A1 (en) 2005-06-16
AR046664A1 (es) 2005-12-14
SI1725229T1 (sl) 2009-08-31
EP1725229A1 (de) 2006-11-29

Similar Documents

Publication Publication Date Title
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
MXPA05011707A (es) Dihidroquinazolinas sustituidas con propiedades antivirales.
UA83875C2 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
MXPA03011039A (es) Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos.
EP1553937A4 (en) GLYCINENITRILE DIPEPTIDYL PEPTIDASE IV INHIBITORS AND METHODS THEREOF
UA87865C2 (en) Hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl)-benzamide, methods for the production thereof, and use thereof as medicaments
MX2007007919A (es) Nuevos derivados de bencilaminas como inhibidores de la proteina de transferencia de colesteril-ester(cetp).
MY146111A (en) Acylaminopyrazoles as fgfr inhibitors
UA84712C2 (en) N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
IL187586A0 (en) Method for producing dihydroquinazolines
IL164509A0 (en) Furyl compounds
TW200504012A (en) Ethynylproline derivatives
IL164613A0 (en) Thienyl compounds
TN2009000109A1 (en) New benzamide derivatives as brad ykinin antagonists
GEP20094638B (en) Benzimidazolone carboxylic acid derivatives
MY141780A (en) 5-substituted quinoline and isoquinoline derivatives, a method for the production thereof and their use as antiphlogistics
MXPA03009548A (es) Arilsulfonamidas como agentes antivirales.
PL1670778T3 (pl) Przegrupowane pentanole, sposób ich wytwarzania i ich zastosowanie jako środków hamujących zapalenia
MXPA05009014A (es) Antagonistas del receptor ccr-3.
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
EP1736157A4 (en) MEDIUM AGAINST JUCKREIZ
MY141020A (en) Novel pparalpha and ppargamma agonists
MY138698A (en) Method for synthesis of (2s)-indoline-2-carboxylic acid, and use in the synthesis of perindopril
MY139159A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
TW200634013A (en) Quinoline derivative, its use, production and pharmaceutical agents containing the derivative